Home » Topics » Infection, BioWorld Science

Infection, BioWorld Science
RSS

FDA clears oral monotherapy for PID

Dec. 31, 1996

New cephalosporins from LG Chemical

Dec. 30, 1996

Lilly describes potential antirhinoviral compounds

Dec. 24, 1996

Forest cleared to market new treatment for cystitis

Dec. 23, 1996

Inex and Bayer end antibiotic research collaboration

Dec. 20, 1996

Tetracycline antibacterial agents under study at Pfizer

Dec. 20, 1996

MedImmune receives patent coverage for RespiGam

Dec. 19, 1996

Carbapenem esters revealed by SKB

Dec. 18, 1996

BMS in-licenses antifungal triazole from Eisai

Dec. 13, 1996

RSV MAb from MedImmune enters pivotal trials

Dec. 13, 1996

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 26, 2026.
Brain-computer interfaces are here but long road ahead
BioWorld
The field of BCI is continually evolving; as such, companies are increasingly highlighting the potential of their technologies to transform care. For advanced...
Next wave of BCI firms builds on pioneers to tackle challenges
BioWorld
With the pace of neurotechnology development accelerating, a wave of brain-computer interface (BCI) companies is emerging on the heels of the pioneers. In the...
ENCALS 2026: From genetics to advancing strategies against ALS
BioWorld Science
Amyotrophic lateral sclerosis (ALS)-associated genes provide direct therapeutic targets and reveal pathways that can be used to develop treatments that counteract...
Boehringer Ingelheim identifies new mGlu3 receptor agonists
BioWorld Science
Boehringer Ingelheim Pharma GmbH & Co. KG and Vanderbilt University have discovered new dihydrobenzoxazine compounds acting as metabotropic glutamate mGlu3...